MLTX Q3 2025 Earnings — MoonLake Immunotherapeutics Revenue & Financial Results | Market Cap Arena

MLTXMoonLake Immunotherapeutics

$1B

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$745,000

Operating Income

-$71M

Net Income

-$70M

EPS (Diluted)

$-1.10

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$45M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$414M

Total Liabilities

$123M

Stockholders' Equity

$289M

Cash & Equivalents

$351M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$745,000	-$32,515	-2191.3%
Operating Income	-$71M	-$43M	-65.7%
Net Income	-$70M	-$35M	-97.0%

Revenue Segments

License

$300M100%